Global Naftifine Hydrochloride Ointment Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Naftifine Hydrochloride Ointment Market Research Report 2024
Naftifine hydrochloride (naftifine), chemically known as (E)-N-Cinnamyl-N-methyl-1-napthalenemethylamine hydrochloride is an antifungal drug used to topically treat fungal infections such as tinea pedis (athletes foot), tinea cruris (jock itch), tinea corporis (ringworm), and others. It is a synthetic allylamine antifungal compound. Naftifine is only prescribed for topical application. This ointment has a complete anti-microbial mechanism of action comprising anti-fungal, anti-bacterial, and anti-inflammatory activity.
According to Mr Accuracy reports’s new survey, global Naftifine Hydrochloride Ointment market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Naftifine Hydrochloride Ointment market research.
Key manufacturers engaged in the Naftifine Hydrochloride Ointment industry include Merz Dermatology, Parchem Fine and Specialty Chemicals, LGM Pharma, Sebela Pharmaceuticals, Erregierre, Simagchem Corporation, Taro Pharmaceutical Industrues, Renaissance Pharma and Shanghai Yisa Biotechnology, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Naftifine Hydrochloride Ointment were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Naftifine Hydrochloride Ointment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Naftifine Hydrochloride Ointment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Merz Dermatology
Parchem Fine and Specialty Chemicals
LGM Pharma
Sebela Pharmaceuticals
Erregierre
Simagchem Corporation
Taro Pharmaceutical Industrues
Renaissance Pharma
Shanghai Yisa Biotechnology
Shaanxi TOP Pharm Chemical
Segment by Type
Adults
Children
Hospital Pharmacy
Retail Pharmacy
E-Commerce
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Naftifine Hydrochloride Ointment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to Mr Accuracy reports’s new survey, global Naftifine Hydrochloride Ointment market is projected to reach US$ million in 2034, increasing from US$ million in 2024, with the CAGR of % during the period of 2023 to 2034. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Naftifine Hydrochloride Ointment market research.
Key manufacturers engaged in the Naftifine Hydrochloride Ointment industry include Merz Dermatology, Parchem Fine and Specialty Chemicals, LGM Pharma, Sebela Pharmaceuticals, Erregierre, Simagchem Corporation, Taro Pharmaceutical Industrues, Renaissance Pharma and Shanghai Yisa Biotechnology, etc. Among those manufacturers, the top 3 players guaranteed % supply worldwide in 2024.
When refers to consumption region, % volume of Naftifine Hydrochloride Ointment were sold to North America, Europe and Asia Pacific in 2024. Moreover, China, plays a key role in the whole Naftifine Hydrochloride Ointment market and estimated to attract more attentions from industry insiders and investors.
Report Scope
This report, based on historical analysis (2018-2024) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Naftifine Hydrochloride Ointment market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Merz Dermatology
Parchem Fine and Specialty Chemicals
LGM Pharma
Sebela Pharmaceuticals
Erregierre
Simagchem Corporation
Taro Pharmaceutical Industrues
Renaissance Pharma
Shanghai Yisa Biotechnology
Shaanxi TOP Pharm Chemical
Segment by Type
Adults
Children
Segment by Application
Hospital Pharmacy
Retail Pharmacy
E-Commerce
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
The Naftifine Hydrochloride Ointment report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source